type here...

CATEGORIES

Pharmaceutics

LATEST

1...567...11Page 6 of 11

TRENDING

EDITORS CHOICE

New Alzheimer’s Drugs Will Worsen Inequality

Julian Willett, MD -
Disclosure: I own a fraction of a share of Eli Lilly stock. We live in a very exciting time! Alzheimer’s medications that are more promising...

Gain of Function Research. Have We Opened Pandora’s Box?

Robert Turner, Founding Editor -
How dangerous is Gain of Function research really and what risks does it pose to us for future pandemics. We explore this branch of science and examine

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Purdue Reformulated OxyContin to Reduce Abuse — Did They Succeed?

Jennifer Mittler-Lee B.S. Pharma -
OxyContin was neither superior to old-fashioned immediate-release oxycodone, a cheaper generic, nor did it offer any advantage over other opioids like morphine.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories